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Several pathogenic bacteria utilize type III secretion
systems (TTSS) to deliver into host cells bacterial
virulence proteins with the capacity to modulate
a variety of cellular pathways. Once delivered into
host cells, the accurate targeting of bacterial effec-
tors to specific locations is critical for their proper
function. However, little is known about the mecha-
nisms these virulence effectors use to reach their
subcellular destination. Here we show that the
Salmonella TTSS effector proteins SspH2 and SseI
are localized to the plasma membrane of host cells,
a process dependent on S-palmitoylation of a con-
served cysteine residue within their N-terminal do-
mains. We also show that effector protein lipidation
is mediated by a specific subset of host-cell palmi-
toyltransferases and that lipidation is critical for
effector function. This study describes a remarkable
mechanism by which a pathogen exploits host-cell
machinery to properly target its virulence factors.
INTRODUCTION
A large number of symbiotic and pathogenic bacteria have
evolved specialized secretion systems to deliver bacterial
proteins, called effectors, into eukaryotic cells to ensure their
survival and replication. Various protein delivery systems have
been described, including type III, type IV, and type VI secretion
systems (Alvarez-Martinez and Christie, 2009; Cornelis, 2006;
Gala´n and Wolf-Watz, 2006; Pukatzki et al., 2009). The enteric
bacterial pathogen Salmonella enterica encodes two virulence-
associated type III secretion systems (TTSS) within its Pathoge-
nicity Islands 1 (SPI-1) and 2 (SPI-2) (Gala´n, 2001; Waterman and
Holden, 2003). The SPI-1 TTSS plays a critical role in the invasion
of nonphagocytic epithelial cells and in the stimulation of inflam-
mation resulting in the onset of diarrhea (Gala´n, 2001). Following
Salmonella internalization into host cells, the SPI-2 TTSS delivers
a distinct set of effectors to promote its intracellular survival and
replication (Waterman and Holden, 2003). Combined, these two
Salmonella TTSSs deliver more than 60 effector proteins, which
in a coordinated manner modulate a variety of host cell path-
ways, including cytoskeletal dynamics, vesicular trafficking,
transcription, cell-cycle progression, signal transduction, andprotein ubiquitination (Gala´n, 2001; Hicks and Gala´n, 2010;
Ibarra and Steele-Mortimer, 2009; McGhie et al., 2009; Water-
man and Holden, 2003). Despite significant progress in our
understanding of the biochemical activity of several Salmonella
effector proteins, the challenge still remains to understand how
these activities are temporally coordinated and spatially orga-
nized to promote Salmonella pathogenesis. Given the com-
plexity and diversity of the biochemical activities associated
with different effectors, the temporal and spatial coordination
of their activities must be precise. However, little is known about
specific mechanisms that target effector proteins to particular
subcellular compartments during infection. It is becoming
increasingly apparent that the host cell itself may play a major
role in effector targeting during infection. For example, the
effector protein SopB is ubiquitinated upon translocation into
host cells, which is required for its specific subcellular locali-
zation and functional diversification (Patel and Gala´n, 2005).
Here we show that two type III secreted effector proteins of
Salmonella Typhimurium, SspH2 and SseI, are S-palmitoylated
by a specific subset of host-cell palmitoyltransferases, resulting
in their targeting to specific domains of the plasma membrane.
We also show that host-mediated posttranslational modification
is required for effector function. This study shows a remarkable
example of how pathogens commandeer host-cell machinery
to spatially coordinate the activities of virulence factors.RESULTS
Targeting of the S. Typhimurium SPI-2 TTSS Effector
SspH2 to the Plasma Membrane Requires
S-Palmitoylation at Its Amino Terminus
We have previously shown that the Salmonella enterica SPI-2
TTSS effector SspH2 belongs to the NEL (novel E3 ligase)
domain family of E3 ubiquitin ligases (Quezada et al., 2009).
NEL E3 ligases comprise a large family of bacterial effector
proteins composed of an N-terminal leucine-rich repeat (LRR)
domain linked by a short stretch of residues to a novel C-terminal
helical domain with ubiquitin ligase activity (Quezada et al., 2009;
Zhu et al., 2008). Unlike other highly related members of this
family, such as SspH1 and SlrP, SspH2 localizes specifically to
the plasma membrane and in particular to the apical membrane
of polarized epithelial cells (Miao et al., 2003; Quezada et al.,
2009). This observation implies that despite their structural
homology, NEL E3 ligase effectors function to differentially
harness the host ubiquitin pathway at unique subcellular
locations to promote pathogenesis. To gain insight into theCell Host & Microbe 10, 9–20, July 21, 2011 ª2011 Elsevier Inc. 9
Figure 1. The N-Terminal Region of SspH2, but Not the LRR Domain, Is Required for Plasma Membrane Localization
(A) Schematic representation of full-length SspH2 and truncation mutants. Full-length SspH2 contains a leucine-rich repeat (LRR) domain (in orange) and a novel
E3 ligase (NEL) domain (in red). The position of its catalytic residue is shown (blue).
(B) Full-length C-terminally FLAG-tagged SspH2 or the indicated SspH2 truncations were transiently expressed in HeLa cells, and their localizationwas examined
by immunofluorescence confocal microscopy using an antibody directed to the FLAG tag (green) and rhodamine-phalloidin to stain polymerized actin (red). XY
panels represent compressed confocal stacks, while XZ panels are single slices through the center of cells of interest. Bar, 10 mm.
(C) HEK293 cells transiently expressing full-length SspH2 or the indicated truncation mutants were fractionated into whole-cell (WC), membrane (M), and
cytosolic (C) fractions. Equal amounts of each fraction were analyzed by SDS-PAGE and immunoblotting with anti-FLAG antibody. Representative fractions were
immunoblotted to detect calnexin and a-tubulin as subcellular fractionation controls.
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infection, we explored the requirements for plasma membrane
targeting of SspH2. We previously showed that the N-terminal
region of SspH2, which contains the LRR domain, targets full-
length SspH2 to the plasma membrane (Quezada et al., 2009).10 Cell Host & Microbe 10, 9–20, July 21, 2011 ª2011 Elsevier Inc.In order to identify the specific domain within the N-terminal
region of SspH2 responsible for plasma membrane localization,
FLAG-tagged truncations of its N-terminal domain were gener-
ated (Figure 1A), transiently expressed in HeLa cells, and local-
ized using indirect immunofluorescence confocal microscopy.
Figure 2. SspH2 Palmitoylation Is Required for Plasma Membrane Localization
(A) Location of the palmitoylation motif at the N terminus of SspH2.
(B) FLAG-tagged SspH2 or the palmitoylation-defective mutant (SspH2C9S) was transiently expressed in HeLa cells, and their localization was examined by
immunofluorescence confocal microscopy using an antibody directed to the FLAG tag (green) and rhodamine-phalloidin to stain polymerized actin (red). XY
panels are compressed confocal stacks, while XZ panels are single slices through the center of cells of interest. Bar, 10 mm.
(C) The palmitic acid reporter Alkynyl-16 (Alk-16) is incorporated into SspH2 only when cysteine 9 is present. HEK293T cells transiently expressing the indicated
FLAG-tagged constructs of SspH2 were metabolically labeled with Alk-16. Labeled cells were lysed and SspH2 immunoprecipitated with an anti-FLAG antibody.
Click-chemistry was performed on the immunoprecipitates utilizing azido-rhodamine, and proteins were separated by SDS-PAGE and imaged by in-gel fluo-
rescence. In parallel, 5% of each cell lysate was immunoblotted with anti-FLAG antibody (lower panel).
(D) FLAG-tagged SspH2 or SspH2C9S were transiently expressed in HeLa cells, and transfected cells were fractionated into whole-cell, membrane, and cytosolic
fractions. Equal amounts of each fraction were analyzed by SDS-PAGE and immunoblotted with anti-FLAG antibody.
(E) SspH2 is modified with palmitic acid via a thioester bond. Alk-16-labeled SspH2was imaged pre- and posttreatment with either 1M Tris or 1M hydroxylamine
by in-gel fluorescence. Following fluorescence imaging, total protein was stained with Coomassie.
(F) Palmitoylation of SspH2 is stable. HEK293T cells transiently expressing SspH2 were pulse labeled with Alk-16 for 30 min and then chased for the indicated
times. Alk-16-labeled SspH2 was imaged as above.
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(SspH21-160) were targeted to the plasmamembrane (Figure 1B).
In contrast, the LRR domain of SspH2 alone (SspH2161-487) was
distributed diffusely throughout the cell cytosol (Figure 1B).
Biochemical fractionation confirmed that the first 160 amino
acids of SspH2 are sufficient and required to partition SspH2
into themembrane fraction (Figure 1C). Therefore, the N-terminal
160 amino acids of SspH2 contain specific plasma membrane
targeting information.
Close examination of the first 160 amino acids of SspH2 re-
vealed a putative eukaryotic S-palmitoylation motif (6GSGC9)
(Figure 2A) (Ren et al., 2008; Xue et al., 2006). S-palmitoylation
is the covalent addition of palmitic acid to a cysteine residue ofCthe target protein through a thioester bond (Smotrys and Linder,
2004). Palmitate addition increases protein hydrophobicity and
can promote membrane association of the modified protein.
To test the contribution of the putative palmitoylation motif to
the steady-state localization of SspH2, we mutated the cysteine
within the motif to a serine and examined its localization after
transient expression in cultured mammalian cells. The resulting
mutant, SspH2C9S, was no longer targeted to the plasma
membrane and instead accumulated in the cytosol (Figures 2B
and 2D), indicating that the Cys9 residue is critical for SspH2
plasma membrane localization. To directly test whether SspH2
is palmitoylated, we utilized bio-orthogonal labeling to detect
the incorporation of the palmitic acid reporter Alkynyl-16ell Host & Microbe 10, 9–20, July 21, 2011 ª2011 Elsevier Inc. 11
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ing SspH2 or different mutant derivatives were metabolically
labeled with Alk-16. SspH2 was immunoprecipitated from cell
lysates and subsequently subjected to on-bead Cu(I)-catalyzed
azide-alkyne cycloaddition (CuAAC) with azido-rhodamine. We
found that Alk-16 was efficiently incorporated into full-length
SspH2 as well as into all truncations that possess the identified
palmitoylation motif (Figure 2C). In contrast, the palmitic acid
reporter was not incorporated into the SspH2C9Smutant, despite
equivalent protein expression levels. To confirm that palmitate
was linked via a thioester bond, Alk-16-labeled SspH2 was
treated with hydroxylamine, which selectively cleaves thioester
bonds. In-gel hydroxylamine incubation resulted in the loss of
the Alk-16 signal compared to treatment with buffer alone
(Figure 2E). These data indicate that SspH2 is modified with
palmitate via a thioester bond. Unlike other lipid modifications,
palmitoylation is reversible, which could lead to dynamic regula-
tion. We therefore measured the turnover of palmitate on SspH2
in cells labeled with Alk-16 for 30 min and chased in medium
lacking Alk-16 for the indicated times.We observed no reduction
in Alk-16 labeling associated with SspH2 even after 8 hr of chase
time (Figure 2F). These results indicate that SspH2 labeling is
stable and therefore does not undergo cycles of palmitoyla-
tion-depalmitoylation, as observed for some palmitoylated pro-
teins. Since the vast majority of SspH2 is membrane associated
and this localization is disrupted when SspH2 is unable to be
palmitoylated, we reason that the bulk of SspH2 is stably
palmitoylated.
We next determined the minimal domain of SspH2 that could
be palmitoylated. We took advantage of the highly related
effector protein SspH1 (Miao et al., 1999), which, despite its
high degree of amino acid sequence similarity with SspH2,
lacks the putative palmitoylation motif at its amino terminus.
We began by replacing the first 17 amino acids of the N-terminal
domain of SspH1 with the first 19 amino acids of SspH2, which
contain the palmitoylation motif (Figure 3A), and examined its
palmitoylation and localization after transient transfection. The
SspH21-19SspH117-700 chimera was not palmitoylated and,
consequently, not targeted to the membrane (Figures 3B and
3C). This result indicates that unlike some proteins in which
palmitoylation motifs are discrete and linear (Bizzozero et al.,
2001; Quesnel and Silvius, 1994), recognition of SspH2 by host
palmitoyltransferases requires more structural information. We
therefore constructed additional chimeras and determined that
the first 100 amino acids of SspH2 are required for its palmitoy-
lation and are sufficient to target the chimeric protein to the
plasma membrane (Figure 3). Taken together, these results indi-
cate that palmitoylation of SspH2 is required for membrane
targeting and that its recognition by palmitoyltransferases
requires determinants contained within its first 100 amino acids.
The S. Typhimurium SPI-2 TTSS Effector SseI
Is Targeted to the Plasma Membrane by an
S-Palmitoylation-Dependent Mechanism
We examined the amino acid sequence of other TTSS effector
proteins for the presence of putative palmitoylation motifs and
identified several effectors (Table S1 and Figure S1), including
SseI, as potential candidates. SseI is a SPI-2 effector protein
that shares significant amino acid sequence identity with the first12 Cell Host & Microbe 10, 9–20, July 21, 2011 ª2011 Elsevier Inc.129 amino acids of SspH2, including Cys9 (Figure 4A) (Miao and
Miller, 2000). First, we examined the localization of FLAG-
epitope-tagged SseI in transiently transfected cells. We found
that, like SspH2, SseI localizes to the plasma membrane of
both nonpolarized (Figure 4B) and polarized (Figure 4E and
Movie S1) cultured cells. We then looked at the potential role
of the putative palmitoylation signal by examining the localization
of SseI carrying a mutation in the predicted palmitoylation site
(SseIC9S). Consistent with the involvement of palmitoylation on
membrane targeting, the SseIC9Smutant exhibited a cytoplasmic
localization (Figures 4B, 4C, and 4E and Movie S1). Metabolic
labeling with Alk-16 revealed that SseI, but not the SseIC9S,
was efficiently palmitoylated (Figure 4D). Taken together, these
results indicate that SseI is also targeted to the membrane in
an S-palmitoylation-dependent manner. Similar to SspH2, the
first 129 amino acids of SseI are palmitoylated and targeted to
the apical domain of the plasmamembrane in polarized epithelial
cells (Figure 4E and Movie S1). However, in contrast to SspH2,
full-length SseI is predominantly localized to the basolateral
domain of the plasma membrane in polarized cells (Figure 4E
and Movie S1). The difference in the localization of SseI in polar-
ized cells in comparison to that of SspH2 suggests that addi-
tional determinants in the C-terminal domain of SseI are likely
required for the protein to reach its final destination within the
plasma membrane of polarized cells.
SspH2 and SseI Are Palmitoylated and Targeted to the
Host-Cell Plasma Membrane during Bacterial Infection
Transient expression in cultured cells leads to effector protein
levels that are much higher than those obtained during bacterial
infection, which could lead to experimental artifacts, particularly
when trying to ascertain effector protein localization. Therefore,
we examined the localization of SspH2 and SseI following
TTSS-mediated translocation during S. Typhimurium infection.
We infected polarized epithelial cells with strains expressing
FLAG-tagged SspH2, SseI, or their respective C9S mutants,
and their localization was examined by confocal microscopy.
Consistent with transient transfection experiments, we found
that both SspH2 and SseI were targeted to the plasma
membrane of infected cells while both SspH2C9S and SseIC9S ex-
hibited a cytoplasmic localization (Figure 5A and Movie S2).
Consistent with these results, we found that both SspH2 and
SseI were palmitoylated only after their translocation by the
TTSS during bacterial infection (Figure 5B). Palmitoylation of
translocated SspH2 and SseI is stable since we observed no
significant reduction in Alk-16 labeling after 3 hr of chase time
(Figure 5C). Taken together, these results demonstrate that
SspH2 and SseI are palmitoylated at Cys9 quickly following their
delivery into host cell and that this modification is required for
their targeting to the plasma membrane during S. Typhimurium
infection.
Identification of Host Palmitoyltransferases Involved
in SspH2 and SseI Palmitoylation
The observation that only translocated SspH2 and SseI are pal-
mitoylated during Salmonella infection together with the finding
that SspH2 and SseI can be palmitoylated when expressed
in cultured cells in the absence of other bacterial effectors
suggests that a host cell enzyme or enzymes are responsible
Figure 3. SspH2 Palmitoylation Requires Information Contained within the First 100 Amino Acids
(A) Schematic representation of full-length SspH2, SspH1, and chimeric mutants.
(B) HEK293T cells transiently expressing the indicated FLAG-tagged constructs weremetabolically labeled with Alk-16. Cells were lysed and immunoprecipitated
with an anti-FLAG antibody. Click-chemistry was performed on the immunoprecipitates utilizing azido-rhodamine, and proteins were separated by SDS-PAGE
and imaged by in-gel fluorescence. In parallel, 5% of each cell lysate was immunoblotted with anti-FLAG antibody (lower panel).
(C) FLAG-tagged SspH1 or chimeric proteins were transiently expressed in HeLa cells, and their localization was examined by immunofluorescence confocal
microscopy using an antibody directed to the FLAG tag and counterstained with rhodamine-phalloidin. XY panels are compressed confocal stacks, while XZ
panels are single slices through the center of cells of interest. Bar, 10 mm.
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toylation is catalyzed by a family of Asp-His-His-Cys (DHHC)
motif containing proteins that have palmitoyltransferase activity
(Greaves and Chamberlain, 2010). In order to identify the eu-
karyotic palmitoyltransferases responsible for palmitoylation of
the Salmonella effector proteins, we cotransfected HEK293
cells with plasmids encoding FLAG-tagged SspH2 and GFP
alone or the GFP-tagged versions of each of the 23 murine
DHHC proteins (Figure S1A). The cells were then labeled with
Alk-16, and the level of palmitoylation of SspH2 was deter-
mined and corrected for total levels of SspH2. We found that
the expression of DHHC-3, -5, -7, -10, and -14 significantly
increased SspH2 palmitoylation (Figures 6A and 6B), suggesting
that these enzymes, by themselves or in a redundant fashion,
may be responsible for the modification of this effector pro-
tein. Analogous results were obtained with SseI, suggestingCthat similar machinery likely modifies both effector proteins
(Figure S1B).
We next examined whether DHHC-3, -5, -7, -10, or -14 could
directly palmitoylate purified SspH2 in vitro. We independently
immunopurified FLAG-tagged SspH2, SspH2C9S, and the indi-
cated DHHC proteins from transfected HEK293 cells and
incubated them in the presence of Alk-16-conjugated coenzyme
A (coA). We found that incubation with either DHHC-3 or
DHHC-7 resulted in the significant incorporation of Alk-16 into
SspH2 and that this labeling required Cys9 since SspH2C9S
was not palmitoylated (Figure 6C). Consistent with the DHHC
dependence of the reaction, no spontaneous Alk-16 labeling of
SspH2 was observed. No incorporation of Alk-16 was seen in
the presence of DHHC-5, -10, or -14. However, the functionality
of the immunoprecipitated enzymes could not be unambigu-
ously ascertained since we observed no autopalmitoylation ofell Host & Microbe 10, 9–20, July 21, 2011 ª2011 Elsevier Inc. 13
Figure 4. Palmitoylated SseI Is Targeted
to the Plasma Membrane
(A) Schematic representation of SspH2 and SseI
highlighting the conservation of the palmitoylation
motif.
(B) FLAG-tagged SseI or SseIC9S was transiently
expressed in HeLa cells, and their localization was
examined by indirect immunofluorescence con-
focal microscopy using an antibody directed to the
FLAG tag (green) and rhodamine-phalloidin to
stain polymerized actin (red). XY panels are
compressed confocal stacks, while XZ panels are
single slices through the center of cells of interest.
Bar, 10 mm.
(C) FLAG-tagged SseI or SseIC9S was transiently
expressed in HEK293 cells. Cells were fraction-
ated into whole-cell, membrane, and cytosolic
fractions. Equal amounts of each fraction were
analyzed by SDS-PAGE and immunoblotted with
anti-FLAG antibody.
(D) HEK293T cells transiently expressing FLAG-
tagged SseI or SseIC9S were metabolically labeled
with Alk-16. Labeled cells were lysed, and SseI or
SseIC9S was immunoprecipitated with an anti-
FLAG antibody. Click-chemistry was performed
on the immunoprecipitates utilizing azido-rhoda-
mine, and proteins were separated by SDS-PAGE
and imaged by in-gel fluorescence. In parallel, 5%
of each cell lysate was immunoblotted for anti-
FLAG antibody (lower panel).
(E) SspH2, SspH2C9S, SspH21-160, SseI, SseIC9S,
or SseI1-129 was transiently expressed in polarized
MDCKII cells, and their localization was examined
by indirect immunofluorescence confocal micro-
scopy using an antibody directed to the FLAG tag
(green), rhodamine-phalloidin to stain polymerized
actin (red), and POPO-1 to stain DNA (blue). XY
panels represent compressed confocal stacks,
while XZ panels are single slices through the
center of cells of interest. Bar, 10 mm. All XZ slices
can be seen as Movie S1.
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cate that a subset of DHHC enzymes can directly palmitoylate
Salmonella effector proteins.
Palmitoylation Is Required for Effector Function
Although the biochemical activity of the NEL family of proteins is
well understood, no phenotype has been associated with
SspH2, therefore preventing the examination of the role of palmi-
toylation on its function. However, SseI has been shown to influ-
ence the directed migration of Salmonella-infected cells14 Cell Host & Microbe 10, 9–20, July 21, 2011 ª2011 Elsevier Inc.(McLaughlin et al., 2009; Worley et al.,
2006). To test whether palmitoylation is
required for SseI function, we examined
the effect of expressing SseI or the palmi-
toylation-deficient mutant SseIC9S on the
ability of cultured cells to migrate. Highly
motile HT-1080 cells were retrovirally
transduced with YFP alone or YFP fused
to either wild-type SseI or SseIC9S, and
the migration of transduced cells wasmonitored by time-lapse microscopy. Consistent with its
reported phenotype, expression of wild-type SseI markedly
inhibited cell migration (Figure 7 and Movie S3). In contrast, cells
expressing palmitoylation-deficient SseIC9S showed no defect in
cell migration. Furthermore, expression of SseI1-129-YFP, which
contains the targeting information but lacks the effector domain
of SseI, did not alter cell migration despite being palmitoylated
and targeted to the plasma membrane (Figure 7 and Movie
S3). Taken together, these results indicate that palmitoylation
is essential for SseI effector function.
Figure 5. Palmitoylated SspH2 and SseI Are Targeted to the Plasma Membrane during Bacterial Infection
(A) Polarized MDCKII cells were infected with mCherry-S. Typhimurium strain (red) expressing wild-type FLAG-tagged SspH2 or SseI or their palmitoylation-
deficient mutant. Eighteen hours postinfection, the cells were examined by indirect immunofluorescence confocal microscopy using an antibody directed to the
FLAG tag (green) and POPO-1 to stain DNA (blue). XY and XZ panels are single slices roughly through the center of infected cells. Bar, 5 mm. All XZ slices can be
seen as Movie S2.
(B) HEK293T cells infected with a S. Typhimurium strain expressing wild-type FLAG-tagged SspH2, SspH2C9S, SseI, or SseIC9S were metabolically labeled with
Alk-16. Cells were lysed and separated into translocated (T) and bacterial (B) fractions. Alk-16-labeled SspH2 was imaged by in-gel fluorescence as described
above. In parallel, 5% of each cell lysate was immunoblotted with anti-FLAG antibody. The asterisk indicates the signal due to IgG heavy chain.
(C) Palmitoylation of translocated SspH2 and SseI is stable. HEK293T cells infected with a S. Typhimurium strain expressing FLAG-tagged SspH2 or SseI were
pulse labeled with Alk-16 for 3 hr and then chased for 3 hr in the absence on Alk-16. Alk-16-labeled SspH2 and SseI were imaged by in-gel fluorescence as
described. In parallel, 5% of each cell lysate was immunoblotted with anti-FLAG antibody. Palmitoylated effector is expressed as a percentage of Alk16-
associated fluorescence remaining after 3 hr compared to 0 hr time point.
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Bacterial pathogens have evolved many different strategies to
modulate or interfere with host cell functions. Arguably, the
simplest strategy involves exotoxins, which usually results in
the delivery of one or two biochemical activities into host cells
with the capacity to interfere with cell functions (Alouf, 2000).
However, pathogens have also evolved more sophisticated
mechanisms, such as the TTSS, which result in the delivery
of multiple bacterial proteins into the same cell (Cornelis, 2006).
Presumably, this strategy evolved out of the need to precisely
modulate complex host cell biological processes in a fashion
that requires many distinct biochemical activities. The chal-
lenge for these systems, however, is to coordinate the timely
delivery of those activities as well as their targeting to the
appropriate subcellular compartment. Recent work has begun
to identify mechanisms that ensure the delivery of TTSS effec-
tors in the appropriate order (Lara-Tejero et al., 2011). How-
ever, less is known about the mechanisms that guarantee theCcorrect targeting of effectors once they are translocated into
host cells.
In this paper, we describe a mechanism that involves the
modification of TTSS effector proteins by host cell machinery
so they are appropriately targeted to their site of action. We
have shown that host-mediated S-palmitoylation of these effec-
tors by specific palmitoyltransferases results in their targeting to
the host cell plasma membrane. We believe this mechanism to
be widespread among effector proteins since we have detected
putative S-palmitoylation signals in effectors from several path-
ogens (Table S1), and we have demonstrated that at least two
of them, members of the Shigella spp. IpaH protein family, are
indeed palmitoylated and targeted to host cell membranes (Fig-
ure S1). S-palmitoylation is a common eukaryotic posttransla-
tional modification characterized by the addition of a saturated
16-carbon palmitic acid to a specific cysteine residue of a protein
through a thioester bond (Smotrys and Linder, 2004). This modi-
fication increases the hydrophobicity of proteins, facilitating their
tethering to intracellular membranes, consequently affectingell Host & Microbe 10, 9–20, July 21, 2011 ª2011 Elsevier Inc. 15
Figure 6. Identification of DHHC Palmitoyl-
transferases Involved in SspH2 Palmitoyla-
tion
(A) HEK293T cells were cotransfected with plas-
mids expressing FLAG-tagged SspH2, GFP, or
the indicated GFP-DHHC palmitoyltransferases.
Transfected cells were labeled with Alk-16, and
SspH2 was immunoprecipitated from cell lysates
with an anti-FLAG antibody. Click-chemistry was
performed on the immunoprecipitates utilizing
azido-rhodamine, and proteins were separated
by SDS-PAGE and visualized by in-gel fluores-
cence. Following fluorescence imaging, gels were
stained with Coomassie to visualize total immu-
noprecipitated protein (lower panel).
(B) Quantification of Alk-16-associated fluores-
cence. The fluorescence signal was normalized to
the total level of SspH2 for each sample and is the
mean ± SD of three independent experiments
(**p < 0.005; *p < 0.01 relative to GFP-expressing
cells). A horizontal dashed line representing the
background level of Alk-16 in the presence of the
GFP vector alone is provided for reference.
(C) DHHC-3 and -7 are able to directly palmi-
toylate SspH2 in vitro. Purified SspH2 and
DHHC proteins were incubated with Alk-16-CoA.
Click-chemistry was performed on the reactions
utilizing azido-rhodamine, and proteins were
separated by SDS-PAGE and imaged by in-gel
fluorescence as indicated above. Following fluorescence imaging, the gel was stained with Coomassie to detect total protein, and representative signals for
SspH2 and SspH2C9S are shown. The faint background signal present in all lanes is due to the high concentration of SspH2 substrate. Additional data are
presented in Figure S1.
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shown to play an important role in regulating protein stability,
protein-protein interactions, and protein activity (Linder and
Deschenes, 2007; Resh, 2006; Smotrys and Linder, 2004). While
uncommon, some bacterial pathogens have been shown to
utilize host lipidation to target virulence proteins within the host
cell. The plant pathogen Pseudomonas syringae encodes a
subset of effectors, including AvrPphB, which are dually lipi-
dated (Dowen et al., 2009; Nimchuk et al., 2000). In addition,
both S. enterica and L. pneumophila encode bacterial effectors
that contain CaaX motifs that are modified by the host lipidation
machinery (Ivanov et al., 2010; Price et al., 2010; Reinicke et al.,
2005).
SspH2 and SseI are most similar to a group of palmitoylated
eukaryotic proteins that are modified on cysteine residues,
usually within the first 25 amino acids of the protein (Smotrys
and Linder, 2004). Other than the presence of cysteines, no addi-
tional sequence motifs have been uncovered that direct palmi-
toylation of this group. However, we found that the palmitoyla-
tion motif of SspH2 alone was unable to direct modification,
and instead palmitoylation and plasma membrane targeting of
a chimeric protein required the first 100 amino acids of
SspH2. Therefore, SspH2 and SseI possess additional sequence
and/or structural information downstream of their palmitoylation
motifs required for modification. Furthermore, palmitoylation
itself, while essential for plasma membrane localization, may
not be sufficient to target these effector proteins to their final
destination. In fact, while the first 120 amino acids (required
for palmitoylation) of both SspH2 and SseI are targeted to the
apical side of the plasma membrane in a palmitoylation-depen-16 Cell Host & Microbe 10, 9–20, July 21, 2011 ª2011 Elsevier Inc.dentmanner, the full-length versions of these effectors ultimately
accumulate in different membrane domains in polarized cells.
While SspH2 primarily localizes to the apical membrane, SseI
is found mainly in the basolateral membrane of polarized cells.
The difference in the localization of SseI in polarized cells in
comparison to SspH2 suggests that additional determinants
located in the C-terminal domain of SseI are likely required for
the protein to reach its final destination within the plasma
membrane.
Eukaryotic palmitoylation is catalyzed by a recently identified
family of DHHC enzymes that have palmitoyltransferase activity
(Greaves and Chamberlain, 2007). DHHC palmitoyltransferases
are polytopic membrane proteins found on a variety of cellular
membranes with a conserved cytoplasmic-facing cysteine-rich
domain that encodes the DHHC catalytic motif. By individually
screening each of the 23 mammalian DHHC family members,
we found that DHHC-3, DHHC-5, DHHC-7, DHHC-10, and
DHHC-14 could significantly enhance palmitoylation of the
Salmonella effectors SspH2 and SseI. All of the identified
enzymes show broad tissue expression, indicating that each is
likely expressed in cell types relevant to Salmonella infection
(Ohno et al., 2006). The ability of multiple DHHC proteins to
modify a single target has been frequently observed (Hou
et al., 2009; Roth et al., 2006). In fact, individual depletion of
the identified DHHC family members by siRNA did not lead to
a reduction in the levels of SspH2 palmitoylation (Figure S2E),
suggesting that these enzymes work in a redundant fashion to
modify this effector protein. Consistent with this observation,
we found that at least two of these enzymes, DHHC-3 and
DHHC-7, were able to directly palmitoylate SspH2 in vitro.
Figure 7. Palmitoylation of SseI Is Required for Its Function
(A) Migration assay of HT1080 cells expressing vector, SseI, SseIC9S, or SseI1-129. Migration of the cells was followed by time-lapse fluorescence microscopy.
Representative still photographs taken at the indicated time points are shown. Bar, 100 mm. The time-lapse movie can be seen in Movie S3.
(B) The migration of the total population of cells is presented as the mean distance traveled of four independent fields of view at the indicated time for each
construct.
(C) Themean total distance traveled after 11 hr by cells expressing each of the indicated constructs is shown for an independent experiment. Error bars represent
the SD. P values were calculated using a two-tailed Student’s t test.
Cell Host & Microbe
Targeting of Virulence Proteins by PalmitoylationInterestingly, DHHC-3 and -7 are grouped together on a branch
of the DHHCphylogenetic tree and have been shown to be active
toward other substrates palmitoylated near the N terminus, such
as PSD-95, GAP-43, and Gaq (Fukata et al., 2004; Skene and
Vira´g, 1989; Tsutsumi et al., 2009). Although no in vitro palmitoy-
lation was seen with purified DHHC-5, -10, or -14, we cannot rule
out that additional cofactors for palmitoyltransferase activity
may be needed for these enzymes to exert their function. For
example, it has been shown that DHHC-9 requires an accessory
protein, GCP16, to form a functional Ras palmitoyltransferase
(Swarthout et al., 2005). The DHHC palmitoyltransferases identi-
fied in this study are not recruited to the Salmonella-containing
vacuole during infection (data not shown), arguing that palmitoy-
lation does not take place at the SCV.
S-palmitoylation is unique from other lipid modifications in
that it is generally reversible and highly dynamic and can be
modulated in response to cell stimulation. Therefore, cycles of
palmitoylation/depalmitoylation can impact protein function by
dynamically controlling membrane association and/or protein-
protein interactions. However, pulse-chase experiments indi-Ccate that S-palmitoylation of SspH2 is remarkably stable, sug-
gesting that once it is translocated and modified, SspH2
becomes stably associated with membranes.
Despite their N-terminal sequence similarity, SspH2 and SseI
possess distinct C-terminal enzymatic domains. SspH2 belongs
to a family of bacterial effectors that possess a C-terminal NEL
E3 ubiquitin ligase domain (Hicks and Gala´n, 2010; Quezada
et al., 2009), while the C-terminal domain of SseI shares amino
acid sequence similarity to a family of bacterial proteins that
possess deamidase activity (McLaughlin et al., 2009). SseI has
been reported to regulate cell migration (McLaughlin et al.,
2009; Worley et al., 2006), and as we have shown here, this
activity requires palmitoylation and plasmamembrane targeting.
Thus, Salmonella appears to have evolved the capacity to exploit
host-dependent N-terminal palmitoylation as a general mecha-
nism to target distinct biochemical activities to the host cell
plasma membrane.
Salmonella enterica utilizes two TTSSs to deliver more than 60
effector proteins into the host cell cytosol during the course of
infection. These effectors interact with and regulate specificell Host & Microbe 10, 9–20, July 21, 2011 ª2011 Elsevier Inc. 17
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their precise temporal and spatial regulation must be coordi-
nated to promote infection. We have shown here that Salmonella
engages host cellular machinery to coordinate the precise
targeting of a subset of its effector proteins to their place of
action. This is another remarkable example of the ability of path-
ogens to harness host cell machinery for their own advantage.
EXPERIMENTAL PROCEDURES
Expression Constructs, Bacterial Strains, and Cell Lines
For eukaryotic expression, full-length SspH2, SspH1, and SseI were amplified
from the S. Typhimurium 14028s genome and cloned into pcDNA3.1 in frame
with a C-terminal 3xFLAG tag as previously described (Quezada et al., 2009).
C-terminally 3xFLAG-tagged truncation mutants were generated by PCR
amplification and subcloned into pcDNA3.1 as above. Palmitoylation mutants
(C9S) were created using 50 primers designed with a point mutation-changing
cysteine codon (TGT) at positions 9 of both SspH2 and SseI to serine (TCT).
Chimeric mutants were generated by PCR, fusing the indicated amino acids
of SspH2 in frame with the indicated amino acids of SspH1 in pcDNA3.1.
DHHC proteins cloned into pEGFP were provided by Masaki Fukata (National
Institute of Physiological Sciences, Japan) (Fukata et al., 2004). Where indi-
cated, DHHC proteins were subcloned in frame with an N-terminal 3xFLAG
tag in pcDNA4/TO (Invitrogen). For bacterial expression, wild-type and C9S
mutants of both SspH2 and SseI were 3xFLAG tagged at the C terminus
and cloned into the arabinose-inducible vector pBAD24 (Guzman et al.,
1995). For retroviral expression, full-length SseI and mutants were subcloned
in frame with a C-terminal YFP tag into pLPCX (Invitrogen). Wild-type pMLV-
GagPol and pVSV-G were kindly provided by Walther Mothes.
Wild-type S. enterica serovar Typhimurium (S. Typhimurium) SL1344 was
used in this study. S. Typhimurium constitutively expressing mCherry was
generated by electroporating S. Typhimurium with pWSK-RpsM-mCherry.
S. Typhimurium infections were performed under Salmonella SP1-1-encoded
TTSS-inducing conditions as previously described (Gala´n and Curtiss, 1990).
Host cells were infected with a multiplicity of 50:1 at 37C for 20 min. Nonad-
herent bacteria were removed, and extracellular bacteria were killed by the
addition of growth medium containing gentamicin (100 mg/ml). Two hours
postinfection, the gentamicin concentration was decreased to 10 mg/ml,
and 0.1% L-arabinose was added to induce expression of the indicated
Salmonella effector under the control of the araBAD promoter.
Fluorescence Microscopy
Cells were transfected with the indicated cDNA using Lipofectamine 2000
(Invitrogen) following the manufacturer’s instructions. Cells were fixed in 4%
paraformaldehyde for 15 min and permeabilized with 0.2% Triton X-100 for
10 min. For localization in polarized cells, MDCKII cells were seeded onto
transwells, transfected with the indicated cDNAs using Lipofectamine 2000,
and fixed once polarized as determined by a transmembrane electrical
resistance of at least 250 U/cm2. Cells were fixed in 4% paraformaldehyde
for 20 min and permeabilized with 0.5% Triton X-100 in PBS buffer containing
1 mg/ml RNase and 2% BSA for 30 min. Coverslips (or transwell membranes)
were incubated with a mouse anti-FLAG M2 antibody (Sigma) diluted in PBS
plus 2% BSA for 1 hr. Coverslips were washed and incubated with anti-mouse
Alexa 488 and, where indicated, with rhodamine-phalloidin and POPO-1
(Invitrogen) to stain DNA. Coverslips were then mounted in ProLong Gold
(Invitrogen). Confocal images were collected at 0.1 mm intervals for 10 mm
(HeLa cells) or 25 mm (MDCKII cells) on an Improvision spinning disc confocal
microscope equipped with a Hamamatsu EM-CCD digital camera using
Volocity software (Improvision).
Cell Fractionation
HEK293 cells were transfected with the indicated cDNA using Lipofectamine
2000. Cells were scraped into PBS, centrifuged 5 min at 4003 g, resuspended
in swelling buffer (10 mM Tris [pH 7.6], 15 mM NaCl, 2 mM MgCl2, and EDTA-
free protease inhibitor cocktail [Roche]) and incubated on ice for 5 min.
Sucrose was added to a final concentration of 8.5%, and cells were broken
by 30 strokes of a dounce homogenizer generating the whole cell fraction.18 Cell Host & Microbe 10, 9–20, July 21, 2011 ª2011 Elsevier Inc.The lysate was centrifuged at 5003 g for 10 min. The supernatant was centri-
fuged at 200,0003 g for 1 hr. The resulting supernatant was collected (cyto-
solic fraction), and the pellet (membrane fraction) was resuspended in swelling
buffer. A final concentration of 1% Triton X-100 was added to each fraction.
Equal volumes of each fraction were analyzed by SDS-PAGE and transferred
to a nitrocellulose membrane. Tagged protein was detected with anti-FLAG
followed by IRDye800-conjugated anti-mouse IgG (Rockland, Gilbertsville,
PA) secondary antibody. Rabbit anti-calnexin (Stressgen) and mouse anti-
a-tubulin (Sigma) were used as controls for subcellular fractions. Immunoblot
images were collected using the Odyssey infrared imaging system (Li-Cor,
Lincoln, NE).
In Vivo Palmitoylation Assay
For transient transfections, HEK293 cells were labeled for 30 min with 50 mM
Alk-16 in DMEMwith 10% FCS. To determine palmitate turnover, labeled cells
were chased in growth medium for the indicated times. Cells were lysed in Brij
lysis buffer (1% Brij-97, 150 mM NaCl, 50 mM triethanolamine [pH 7.4]) with
EDTA-free protease inhibitor cocktail on ice. Immunoprecipitations were
performed using anti-FLAG-M2 affinity resin (Sigma). The immunoprecipitates
were washed three times with 1 ml of ice-cold modified RIPA buffer (1% Triton
X-100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM triethanolamine [pH
7.4], 150 mM NaCl). The beads were resuspended in 40 ml of SDS buffer
(4% SDS, 50 mM triethanolamine [pH 7.4], 150 mM NaCl) and 3 ml premixed
click-chemistry reaction mixture (azido-rhodamine [100 mM, 10 mM stock
solution in DMSO], Tris [2-carboxyethyl] phosphine hydrochloride [TCEP]
[1 mM, 50 mM freshly prepared stock solution in deionized water], Tris
[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine [TBTA] [100 mM, 10 mM stock
solution in DMSO] and CuSO4$5H2O [1 mM, 50 mM freshly prepared stock
solution in deionized water]). Reactions were incubated with shaking for 1 hr
at 30C. The reactions were diluted with 5 3 SDS-PAGE buffer (250 mM Tris
[pH 6.8], 10% SDS, 50% glycerol, 0.5% bromophenol blue) and 0.5% 2-mer-
captoethanol and incubated for 20 min at 37C. Reactions were resolved by
SDS-PAGE, and in-gel fluorescence was performed.
For S. Typhimurium infection experiments, HEK293 cells were infected with
S. Typhimurium expressing arabinose-inducible FLAG-tagged SspH2, SseI, or
their respective palmitoylation mutants. Ten hours postinfection, infected cells
were labeled for 5 hr with 50 mMAlk-16. To determine palmitate turnover during
infection, cells were labeled for 3 hr and chased in normal growth medium for
3 hr. Infected cells were lysed in Brij lysis buffer on ice and centrifuged at
14,000 rpm for 20 min at 4C. Supernatant was collected (translocated frac-
tion), and the pellet (bacterial fraction) was resuspended in 10% SDS, 1%
Triton X-100, 0.5% sodium deoxycholate, 150 mM NaCl, 50 mM triethanol-
amine (pH 7.4), 2 mM EDTA, and protease inhibitor cocktail and boiled for
5m.SDSconcentrationwas adjusted to 0.1%SDS.Each fractionwas immuno-
precipitated and subjected to on-bead click-chemistry reaction as described.
Alk-16-CoA Synthesis
Alk-16-CoA was synthesized from Alk-16 and coA using acyl-CoA synthetase
as previously described for [3H]palmitoyl-CoA (Veit et al., 2002). Briefly, acyl-
CoA synthetase (2 ml, 10 mg/ml in phosphate buffer from Pseudomonas fragi)
(Sigma) was incubated for 10 min at 28C with coenzyme A (3 ml, 10 mM in
distilled water), Alk-16 (3 ml, 5 mM in ethanol), 1 mM ATP, and 4 mM MgSO4
in a final volume of 50 ml phosphate buffer (pH 7.4). The reaction was stopped
by adding 1ml acetonitrile/1Mphosphoric acid (9:1), and precipitated proteins
were pelleted (10 min, 5000 x g). The supernatant was extracted three times
with 1 ml of toluene to remove the unreacted Alk-16. After the final extraction,
the aqueous phase was discarded, and Alk-16-CoA adhering to the vial was
resuspended in 200 ml 50 mM MES (pH 6.5), 150 mM NaCl, 0.025% Triton
X-100.
In Vitro Palmitoylation Assay
HEK293 cells were transfected with cDNA for FLAG-tagged SspH2,
SspH2C9S, and DHHC proteins using Lipofectamine 2000 following the manu-
facturer’s instructions. FLAG-tag protein was purified using M2 anti-FLAG
agarose beads. FLAG-tagged recombinant proteins were eluted with 50 mM
morpholineethanesulfonic acid (MES) (pH 6.3), 150 mM NaCl, 0.05% Triton
X-100, and 250 mg/ml FLAG peptide (Sigma). SspH2 or SspH2C9S was mixed
with the indicated DHHC protein, Alk-16-CoA was added, and the reaction
Cell Host & Microbe
Targeting of Virulence Proteins by Palmitoylationwas incubated for 1 hr at 30C. SDS was added to a final concentration of 4%.
Click-chemistry was performed on each sample with azido-rhodamine as
described. Proteins were resolved by SDS-PAGE, followed by in-gel fluores-
cence and Coomassie imaging.
In-Gel Fluorescence Imaging
After proteins were separated by SDS-PAGE, gels were fixed for 20 min with
50%MeOH and 7.5% acetic acid and then washed twice with water for a total
of 1 hr. Palmitoylated protein was visualized by directly scanning (excitation
532 nm, 580 nm filter, 30 nm band pass) the gel on a Typhoon 9400 imager
(GE Healthcare). Images were processed and analyzed using the ImageQuant
TL software (GE Healthcare). To quantitate the relative palmitoyltransferase
activity due to overexpression of DHHC proteins, the fluorescence of palmitoy-
lated SspH2 was corrected for total SspH2 measured by Coomassie staining.
Retroviral Transduction and Migration Assay
HT-1080 cells were transduced using retroviral vectors encoding SseI-YFP
(pLPCX-SseI-YFP), SseIC9S-YFP (pLPCX-SseIC9S), SseI1-129-YFP (pLPCX-
SseI1-129-YFP), or YFP alone (pLPCX-YFP) with virus generated as previously
described (Sherer et al., 2003). For retroviral transduction, 1 3 105 HT1080
cells were incubated with viral supernatant in the presence of 8 mg/ml poly-
brene for 16 hr. Transduced cells were plated in one half of an Ibidi culture
insert (Ibidi, Martinsried, Germany) in an eight-chamber fibronectin-coated
slide. Once confluent, the fetal calf serum concentration was reduced to
1%, and the Ibidi culture inserts were removed. Live imaging of cell migration
was performed at 37Cby using a 203 objective of a Improvision spinning disc
confocal microscope equipped with a Nikon TE2000 base and a Hamamatsu
EM-CCD digital camera using Volocity software. The time-lapse acquisition of
the focal plane with the highest YFP fluorescence intensity was captured every
30 min. Live cell imaging experiments were carried out a minimum of three
times in order to confirm reproducibility. Movies were edited and analyzed
using the ImageJ (NIH) 1.45c7 software package (http://imagej.nih.gov/ij). At
each time point, the area of the image containing cells was calculated using
YFP fluorescence intensity. The difference in the area containing cells for
each time point was used to calculate the distance traveled by the cells.
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